Products Categories
CAS No.: | 3836-23-5 |
---|---|
Name: | 17alpha-Ethynyl-19-nortestosterone 17-heptanoate |
Article Data: | 3 |
Molecular Structure: | |
Formula: | C27H38O3 |
Molecular Weight: | 410.597 |
Synonyms: | 19-Nor-17a-pregn-4-en-20-yn-3-one, 17-hydroxy-, heptanoate(6CI,7CI,8CI);Heptanoic acid, ester with 17-hydroxy-19-nor-17a-pregn-4-en-20-yn-3-one (8CI);17a-Ethynyl-19-nortestosterone 17-heptanoate;NSC 22846;Norethindrone enanthate;Norethisterone heptanoate;Norigest;Noristerat;SH 8.0393;ZK 5410; |
EINECS: | 223-326-7 |
Density: | 1.08 g/cm3 |
Melting Point: | 69.5°C |
Boiling Point: | 515.3 °C at 760 mmHg |
Flash Point: | 219 °C |
PSA: | 43.37000 |
LogP: | 6.01380 |
What can I do for you?
Get Best Price
The Norethisterone enanthate is an organic compound with the formula C27H38O3. The IUPAC name of this chemical is [(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate. With the CAS registry number 3836-23-5, it is also named as Noristerat. The product's classification codes are Contraceptive Agents; Contraceptive agents, female; Contraceptives, Oral; Contraceptives, oral, synthetic; Drug / Therapeutic Agent; Hormone; Human Data; Reproductive Control Agents; Reproductive Effect; Tumor data.
Physical properties about Norethisterone enanthate are: (1)ACD/LogP: 6.65; (2)# of Rule of 5 Violations: 1 ; (3)#H bond acceptors: 3; (4)#Freely Rotating Bonds: 7; (5)Polar Surface Area: 43.37 Å2; (6)Index of Refraction: 1.54; (7)Molar Refractivity: 118.28 cm3; (8)Molar Volume: 376.8 cm3; (9)Polarizability: 46.89×10-24cm3; (10)Surface Tension: 44.2 dyne/cm; (11)Density: 1.08 g/cm3; (12)Flash Point: 219 °C; (13)Enthalpy of Vaporization: 78.72 kJ/mol; (14)Boiling Point: 515.3 °C at 760 mmHg; (15)Vapour Pressure: 9.93E-11 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C4\C=C3/C(C2CCC1(C(CCC1(C#C)OC(=O)CCCCCC)C2CC3)C)CC4
(2)InChI: InChI=1/C27H38O3/c1-4-6-7-8-9-25(29)30-27(5-2)17-15-24-23-12-10-19-18-20(28)11-13-21(19)22(23)14-16-26(24,27)3/h2,18,21-24H,4,6-17H2,1,3H3
(3)InChIKey: APTGJECXMIKIET-UHFFFAOYAS
(4)Std. InChI: InChI=1S/C27H38O3/c1-4-6-7-8-9-25(29)30-27(5-2)17-15-24-23-12-10-19-18-20(28)11-13-21(19)22(23)14-16-26(24,27)3/h2,18,21-24H,4,6-17H2,1,3H3
(5)Std. InChIKey: APTGJECXMIKIET-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
women | TDLo | intramuscular | 4mg/kg (4mg/kg) | BLOOD: "CHANGES IN SERUM COMPOSITION (E.G., TP, BILIRUBIN, CHOLESTEROL)" | Shengzhi Yu Biyun. Reproduction and Contraception. Vol. 12(4), Pg. 13, 1992. |
women | TDLo | intravenous | 4mg/kg (4mg/kg) | SENSE ORGANS AND SPECIAL SENSES: INCREASED INTRAOCULAR PRESSURE: EYE | Advances in Planned Parenthood. Vol. 8, Pg. 103, 1972. |